Tag: Gilead
Remdesivir did not reduce hospital stay or death in COVID-19 patients:...
According to the clinical trials by the World Health Organization (WHO), Gilead Sciences Inc's Remdesivir had little or no effect on COVID-19 patients’ span...
COVID-19 victims recover faster with Gilead’s antiviral drug
A recent 1,062-patient study published in the New England Journal of Medicine revealed that antiviral drug Remdesivir by American biopharmaceutical company Gilead Sciences Inc...
AstraZeneca sees a 2% drop in valuation amid rumors of a...
U.K.-based pharmaceutical firm AstraZeneca witnessed a 2% drop in its share prices as a result of recent reports that it had approached its U.S....
